Human visceral leishmaniasis expresses Th1 pattern in situ liver lesions

Journal of Infection

Volumn 57, Issue 4, 2008, Pages 332-337

  Seixas Duarte, Maria Irma ^a   Tuon, Felipe Francisco ^b   Pagliari, Carla ^a   Kauffman, Monica R ^a   Brasil, Roosecelis Araujo ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Immune response; Leishmania; Leishmaniasis; Visceral leishmaniasis

Indexed keywords

CD20 ANTIGEN; CD57 ANTIGEN; CD68 ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; MEGLUMINE; TUMOR NECROSIS FACTOR ALPHA;

AMASTIGOTE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; ENZYME ACTIVITY; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEISHMANIA; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; TH1 CELL; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIGENS, PROTOZOAN; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEISHMANIA; LEISHMANIASIS, VISCERAL; LIVER; TH1 CELLS;

EID: 53249111248     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.07.005     Document Type: Article

References (35)

1. Andrade Z.A., and Andrade S.G. Some new aspects of the kala-azar pathology. (Morphologic study of 13 autopsy cases). Rev Inst Med Trop Sao Paulo 8 (1966) 259-266
2. Giraud P. Importance des lesions hepatiques au cours de la leishmaniose viscerale (Kala-azar). Rev Int Hepatol 6 (1956) 769-777
3. Meleney H.E. The histopathology of Kala-azar in the hamster, monkey and man. Am J Pathol 1 (1925) 147-168
4. Duarte M.I., and Corbett C.E. Histopathological patterns of the liver involvement in visceral leishmaniasis. Rev Inst Med Trop Sao Paulo 29 (1987) 131-136
5. Gutierrez Y., Maksem J.A., and Reiner N.E. Pathologic changes in murine leishmaniasis (Leishmania donovani) with special reference to the dynamics of granuloma formation in the liver. Am J Pathol 114 (1984) 222-230
6. Tafuri W.L., Tafuri W.L., Barbosa A.J., Michalick M.S., Genaro O., França-Silva J.C., et al. Histopathology and immunocytochemical study of type 3 and type 4 complement receptors in the liver and spleen of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Rev Inst Med Trop Sao Paulo 38 (1996) 81-89
7. Tafuri W.L., Michalick M.S., Dias M., Genaro O., Leite V.H., Barbosa A.J., et al. Optical and electron microscopic study of the kidney of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Rev Inst Med Trop Sao Paulo 31 (1989) 139-145
8. Stager S., Alexander J., Carter K.C., Brombacher F., and Kaye P.M. Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infect Immun 71 (2003) 4804-4807
9. Wilson M.E., and Weinstock J.V. Hepatic granulomas in murine visceral leishmaniasis caused by Leishmania chagasi. Methods 9 (1996) 248-254
10. Wilson M.E., Sandor M., Blum A.M., et al. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J Immunol 156 (1996) 2231-2239
11. Amato V.S., de Andrade H.F., and Duarte M.I. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop 85 (2003) 39-49
12. Tuon F.F., Amato V.S., Floeter-Winter L.M., et al. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - first report. Int J Dermatol 46 (2007) 628-630
13. Hsu S.M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29 (1981) 577-580
14. Moussallem T.M., Guedes F., Fernandes E.R., et al. Characterization of cellular phenotypes and cytokine expression in balt from children with congenital heart diseases. Pediatr Pathol Mol Med 22 (2003) 449-459
15. d'Avila S.C., Pagliari C., and Duarte M.I. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 156 (2003) 51-60
16. Cuba-Cuba C.A., Evans D., Rosa A.C., and Marsden P.D. Clonal variation within a mucosal isolate derived from a patient with Leishmania (Viannia) braziliensis infection. Rev Inst Med Trop Sao Paulo 33 (1991) 343-350
17. Duarte M.I., Mariano O.N., and Corbett C.E. Liver parenchymal cell parasitism in human visceral leishmaniasis. Virchows Arch A Pathol Anat Histopathol 415 (1989) 1-6
18. Holaday B.J. Role of CD8+ T cells in endogenous interleukin-10 secretion associated with visceral leishmaniasis. Mem Inst Oswaldo Cruz 95 (2000) 217-220
19. Gomes-Pereira S., Rodrigues O.R., Rolao N., Almeida P.D., and Santos-Gomes G.M. Hepatic cellular immune responses in mice with "cure" and "non-cure" phenotype to Leishmania infantum infection: importance of CD8+ T cells and TGF-beta production. FEMS Immunol Med Microbiol 41 (2004) 59-68
20. Denkers E.Y., and Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11 (1998) 569-588
21. Diaz N.L., Arvelaez F.A., Zerpa O., and Tapia F.J. Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis. Clin Exp Dermatol 31 (2006) 114-117
22. Liew F.Y., Li Y., and Millott S. Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from l-arginine. Immunology 71 (1990) 556-559
23. Kumar R., Pai K., and Sundar S. Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis. Clin Exp Immunol 124 (2001) 262-265
24. Laurenti M.D., Sotto M.N., Corbett C.E., da M.V., and Duarte M.I. Experimental visceral leishmaniasis: sequential events of granuloma formation at subcutaneous inoculation site. Int J Exp Pathol 71 (1990) 791-797
25. Gaya D.R., Thorburn D., Oien K.A., Morris A.J., and Stanley A.J. Hepatic granulomas: a 10 year single centre experience. J Clin Pathol 56 (2003) 850-853
26. Gazzinelli R.T., Wysocka M., Hayashi S., et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153 (1994) 2533-2543
27. Stobie L., Gurunathan S., Prussin C., et al. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci U S A 97 (2000) 8427-8432
28. Kirkpatrick C.E., and Farrell J.P. Splenic natural killer-cell activity in mice infected with Leishmania donovani. Cell Immunol 85 (1984) 201-214
29. Kirkpatrick C.E., Farrell J.P., Warner J.F., and Denner G. Participation of natural killer cells in the recovery of mice from visceral leishmaniasis. Cell Immunol 92 (1985) 163-171
30. Kaye P.M., and Bancroft G.J. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun 60 (1992) 4335-4342
31. Ishikawa H., Hisaeda H., Taniguchi M., et al. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 12 (2000) 1267-1274
32. Cillari E., Dieli M., Maltese E., Milano S., Salerno A., and Liew F.Y. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J Immunol 143 (1989) 2001-2005
33. Zwingenberger K., Harms G., Pedrosa C., et al. Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-alpha and IL-1 beta production. Immunobiology 183 (1991) 125-132
34. Curry A.J., and Kaye P.M. Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani. Infect Immun 60 (1992) 4422-4426
35. Raz E. Organ-specific regulation of innate immunity. Nat Immunol 8 (2007) 3-4